دوره 33، شماره 162 - ( Special Issue 1404 )                   جلد 33 شماره 162 صفحات 48-40 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abdulfattah A K, Allami R H, Shareef S A. Impact of Interleukin-18 Genetic Polymorphisms on the Susceptibility to Hashimoto’s Thyroiditis in Iraqi Patients. J Adv Med Biomed Res 2025; 33 (162) :40-48
URL: http://journal.zums.ac.ir/article-1-7848-fa.html
Impact of Interleukin-18 Genetic Polymorphisms on the Susceptibility to Hashimoto’s Thyroiditis in Iraqi Patients. Journal of Advances in Medical and Biomedical Research. 1404; 33 (162) :40-48

URL: http://journal.zums.ac.ir/article-1-7848-fa.html


چکیده:   (123 مشاهده)

Background & Objective: Hashimoto’s Thyroiditis (HT) is one of the prevalent autoimmune thyroid disorders. This disease is characterized by chronic lymphocytic infiltration and progressive thyroid tissue destruction. The development of HT is influenced by the complex interplay between immunological and genetic factors. This study aimed to investigate the association between gene polymorphisms of Interleukin-18 (IL-18), a pro-inflammatory cytokines, and susceptibility to HT in Iraqi population. In particular, three single nucleotide polymorphisms (SNPs): (rs1946518, rs187238, and rs1946519) were examined and analyzed to enhance the understanding of the genetic contribution of IL-18 polymorphisms to HT pathogenesis, thereby supporting the improvement of early diagnosis, treatment, and prevention strategies.
 Materials & Methods: The total number of participants included in this study was 100. The patients who were diagnosed with HT were 50 and the healthy were 50 representing the control group. The study was conducted using standard molecular biology methods including genotyping of the samples via sequencing techniques. Statistical methods were subsequently applied to analyze the results of the distribution of alleles and genotypes.
Results:  We observed no significant difference in the genotype or allele frequency of rs1946518 between HT patients and healthy controls. The results of rs187238 demonstrate no genetic variation in the study population: all samples exhibited the homozygous wild-type genotype, suggesting that this SNP may not be polymorphic in the Iraqi population. Similarly, rs1946519 displayed no significant differences among the patient and control groups.
Conclusion:  In conclusion, the examined IL-18 gene polymorphisms showed a non-significant correlation with HT in the observed Iraqi samples. It is recommended to continue the research on this topic with larger sample sizes and include more diverse groups.

متن کامل [PDF 690 kb]   (2 دریافت)    
نوع مطالعه: مقاله پژوهشی | موضوع مقاله: Medical Biology
دریافت: 1404/6/31 | پذیرش: 1404/8/24 | انتشار: 1404/10/8

فهرست منابع
1. Wilson SA, Stem LA, Bruehlman RD. Hypothyroidism: Diagnosis and Treatment. Am Fam Physician. 2021;103(10):605-13.
2. Mahmood AM, Allami RH, Issa YW. Impact of single nucleotide polymorphisms of immune checkpoint CTLA-4 (SNP rs231775 and rs5742909) in susceptibility to Hashimoto's thyroiditis patients. J Adv Biotechnol Exp Ther. 2023;6(3):23-33. [DOI:10.5455/jabet.2024.d02]
3. Martinez Quintero B, Yazbeck C, Sweeney LB. Thyroiditis: Evaluation and Treatment. Am Fam Physician. 2021;104(6):609-17.
4. Wrońska K, Hałasa M, Szczuko M. The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge. Int J Mol Sci. 2024;25(13):6883. [DOI:10.3390/ijms25136883] [PMID] [PMCID]
5. Moini J, Pereira K, Samsam M. Epidemiology of thyroid disorders: Elsevier; 2020. [DOI:10.1016/B978-0-12-818500-1.00001-3]
6. Ali Shareef S, Allami RH, Al-ezzy RM, editors. Correlation between Interleukin-23, Autoantibodies and Thyroid Profile in a Sample of Iraqi Patients with Hashimoto's Thyroiditis. Bristol, United Kingdom: IOP Publishing. 2024. [DOI:10.1088/1755-1315/1325/1/012024]
7. Sawsan AO, Elmubarak M. Causes and Management of Hypothyroidism. In:Hypothyroidism - Causes, Screening and Therapeutic Approaches. London, United Kingdom: IntechOpen. 2024. [DOI:10.5772/intechopen.1005433]
8. Atkinson A, Esenabhalu V. Hashimoto's Disease: Associated Thyroid Gland Disorders, Pharmacological, and Nutritional Interventions. Open J End Metab Dis. 2022;12(10):211-24. [DOI:10.4236/ojemd.2022.1210016]
9. Mahmood AM, Allami RH, Issa YW. Impact of single nucleotide polymorphisms of immune checkpoint CTLA-4 (SNP rs231775 and rs5742909) in susceptibility to Hashimoto's thyroiditis patients. J Adv Biotechnol Exp Ther. 2023;7(1):23-33. [DOI:10.5455/jabet.2024.d02]
10. Shareef SA, Al-ezzy RM, Allami RH. Cytogenetic Analysis Associated with Hashimoto's Thyroiditis in Samples of Iraqi Patients: an in vitro study. J Biotechnol Res Cent. 2024;18(2):65-72. [DOI:10.24126/jobrc.2024.18.2.790]
11. Iwamoto Y, Kimura T, Itoh T, Mori S, Sasaki T, Sugisaki T, et al. Structural and functional differences in auto-antibody positive compared to auto-antibody negative hypothyroid patients with chronic thyroiditis. Sci Rep. 2023;13(1):15542. [DOI:10.1038/s41598-023-42765-z] [PMID] [PMCID]
12. Li J, Huang Q, Sun S, Zhou K, Wang X, Pan K, et al. Thyroid antibodies in Hashimoto's thyroiditis patients are positively associated with inflammation and multiple symptoms. Sci Rep. 2024;14(1):27902. [DOI:10.1038/s41598-024-78938-7] [PMID] [PMCID]
13. Li C, Zhou J, Huang Z, Pan X, Leung W, Chen L, et al. The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy. Dis Markers. 2020;2020:8871951. [DOI:10.1155/2020/8871951] [PMID] [PMCID]
14. Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D. The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmun Rev. 2020;19(9):102617. [DOI:10.1016/j.autrev.2020.102617] [PMID]
15. Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973. [DOI:10.3389/fimmu.2022.919973] [PMID] [PMCID]
16. Liu Z, Wang H, Xiao W, Wang C, Liu G, Hong T. Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis. Int J Exp Pathol. 2010;91(5):420-5. [DOI:10.1111/j.1365-2613.2010.00715.x] [PMID] [PMCID]
17. Storjord E, Hennø LT, Mollnes TE, Brekke OL. Analysis of cytokines. Tidsskr Nor Laegeforen. 2020;140(1). [DOI:10.4045/tidsskr.18.0961] [PMID]
18. Waxman C, Lind T. Blood sample collection and handling. In Advanced monitoring and procedures for small animal emergency and critical care. dling. In Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care. (eds Burkitt Creedon JM, Davis H). Hoboken, NJ, USA: John Wiley & Sons, Inc. 2023. pp. 699-715. [DOI:10.1002/9781119581154.ch53]
19. Al Her MH, Al-Juhaishi AMR, Hm AA. Effect of CYP2D6* 10 (100C> T) Polymorphisms on Clomiphene Citrate Response in Iraqi Women with PCOS. Karbala J Pharm Sci. 2025;16(26):125-36. [DOI:10.62472/kjps.v16.i26.125-136]
20. Bruijns B, Hoekema T, Oomens L, Tiggelaar R, Gardeniers H. Performance of spectrophotometric and fluorometric DNA quantification methods. Analytica. 2022;3(3):371-84. [DOI:10.3390/analytica3030025]
21. Khehra N, Padda IS, Zubair M. Polymerase Chain Reaction (PCR). 2025. StatPearls Publishing, Treasure Island (FL).
22. Belmont J. 96 - Molecular Methods. In: Fifth, editor. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors Clinical Immunology: London, United Kingdom: Elsevier; 2019. pp. 1297-310.e1.
23. Sadiq NA-HS, Aziz DZ. The interplay between IL-18 rs1946518 polymorphism, TSH dysregulation, and vitamin D3 deficiency in Hashimoto's thyroiditis. Human Gene. 2025;46:201465. [DOI:10.1016/j.humgen.2025.201465]
24. Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, et al. Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease. Ann N Y Acad Sci. 2003;1005:436-9. https://doi.org/10.1196/annals.1288.074 [DOI:10.1196/annals.1288.055] [PMID]
25. Huang CY, Ting WH, Lo FS, Wu YL, Chang TY, Chan HW, et al. The IL18 gene and Hashimoto thyroiditis in children. Hum Immunol. 2013;74(1):120-4. [DOI:10.1016/j.humimm.2012.10.005] [PMID]
26. Karakaya D, Çakmak Genc G, Karakas Celik S, Aktas T, Bayraktaroglu T, Dursun A. Association between IL-18 gene polymorphisms and Hashimoto thyroiditis. Mol Biol Rep. 2021;48(10):6703-8. [DOI:10.1007/s11033-021-06659-5] [PMID]
27. Pan HF, Leng RX, Ye DQ. Lack of association of interleukin-18 gene promoter− 607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus. 2011;20(9):945-51. [DOI:10.1177/0961203311400114] [PMID]
28. Inoue N, Watanabe M, Nakaguchi A, Ueda D, Kawaguti H, Hidaka Y, et al. Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases. Endocr J. 2017;64(7):695-703. [DOI:10.1507/endocrj.EJ16-0551] [PMID]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2026 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb